Skip to content

Long term impact of targeted drug counselling intervention on medication adherence in Inflammatory Bowel Disease patients

Long term impact of targeted drug counselling intervention on medication adherence in Inflammatory Bowel Disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000094471
Enrollment
116
Registered
2016-01-29
Start date
2011-10-12
Completion date
2015-05-21
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Psychological factors are often underrepresented although important in medication adherence. Interventions geared towards education may help facilate adherence. Two questionnaires were administered to screen IBD patients. The Medication Adherence Rating Scale (MARS) questionnaire screened for non-adherence and consisted of four questions on a Likert-type scale. The Beliefs about Medications Questionnaire (BMQ) addressed necessity and concerns. The BMQ consisted of ten questions on a 5-point Likert scale The first five questions addressed patient necessity towards medications and the last five questions addressed patient concerns regarding medications totalling a maximum of 25 points per domain. High necessity and concerns was determined with a score of >15/25 in each corresponding domain. Patients with MARS scores below 17 were classified as non-adherers and were offered a structured personalised counselling session with an IBD pharmacist addressing misperceptions, concerns, risk and other queries. Adherers were recruited as controls. All patients were followed up with the MARS and BMQ questionnaire on a three-monthly basis for a maximum of two years or until the study period had elapsed. The primary outcome was adherence measured by the MARS score. Secondary outcomes were medication necessity, concerns and acceptance. Medication acceptance was defined as high necessity >15/25 and low concerns score <16/25.

Interventions

Patients are given two screening questionnaires to determine if they are adherers or non-adherers The Medication Adherence Rating Scale (MARS) is a validated questionnaire that represents medication adherence comprising of 4 simple questions. A score below 17 represents medication non-adherence. The Beliefs about Medication Questionnaire (BMQ) is a validated questionnaire assessing a subjects perception of necessity of medications and concerns about medications. This questionnaire helps guide

Patients are given two screening questionnaires to determine if they are adherers or non-adherers The Medication Adherence Rating Scale (MARS) is a validated questionnaire that represents medication adherence comprising of 4 simple questions. A score below 17 represents medication non-adherence. The Beliefs about Medication Questionnaire (BMQ) is a validated questionnaire assessing a subjects perception of necessity of medications and concerns about medications. This questionnaire helps guide the direction of the counselling / educational intervention. Patients identified as non-adherers are assigned to the intervention group and will receive a ONCE off personal (one on one) drug counselling session with an experienced IBD pharmacist lasting approximately 20 minutes. Further questionnaires are given out on a 3 monthly basis to monitor for changes in adherence and to detemine the effectiveness of the intervention

Sponsors

Professor Rupert Leong
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Confirmed diagnosis of IBD

Exclusion criteria

Not taking medications at the time of screening Incomplete questionnaires at screening.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026